<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221027056320N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-12-02</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Preparation and evaluation of a new dressing aim to treat dry socket</public_title>
      <acronym></acronym>
      <scientific_title>Preparation and in-vitro and in-vivo evaluation of a lipid-liquid crystal gel dressing containing eugenol and iodoform aim to treatment of alveolar osteitis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-11-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/66582</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: For the required number of samples, identical envelopes are prepared, half of them are marked as group one and the other half as group two, the envelopes are sealed, patients are randomly assigned to one of the two groups by choosing an envelope, Blinding description: The participant randomly chooses one of the envelopes and based on the selected code, one of the drugs (test and control) is placed in the patient's socket. Since the patient does not know which drug is the test and which is the control, and it is not posible  to see the drug inside the socket, the study is blind for the participant.

The clinical caregiver is selected among the nurses. The test and control drugs are delivered to them in similar containers, and they will not know which drug is the control or the test.

The outcome evaluator and data analyzer receive patient information based on the code and will not know which code is related to the control drug or  the test drug.</study_design>
      <phase>3</phase>
      <hc_freetext>alveolar osteitis (dry socket).</hc_freetext>
      <i_freetext>Intervention 1: Control group: applying sufficient amount of alveogel manufactured by the Turkish company "Kalsin" in the tooth socket so that it fills the socket and repeating it every 24 hours in case of pain and upon the request of the patient until the complete pain relief. Intervention 2: Intervention group: applying sufficient amount of liquid crystal gel dressing, prepared in Mashhad Faculty of Pharmacy, in the tooth socket so that it fills the socket and repeating it every 24 hours in case of pain and upon the patient's request until the complete pain relief.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All personal data of study participants can be shared after anonymization.

When:
Beginning of the access period, 6 months after the publication of the results.

To whom:
All applicants in academic and non-academic sectors can apply to receive data after authentication..

Conditions:
For use in the academic sector, the source of the data must be mentioned and the copyright must be respected. If it is used in the industrial sector leading to product production, the royalties of the researchers involved in the study should be included.

Where to obtain:
To receive data, send an email containing your introduction and the reason for needing data to the following address:
Amirhossein Chavoshi
The first researcher of the study
ahch1378@gmail.com

How to obtain:
1. Sending an email containing specifications and reasons for the need for data
2. Completing the sent questionnaire form
3. Authentication and consent of all researchers to release data
4. Sending data to the applicant

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amirhossein Chavoshi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 4, No. 5, at the Hekmat sq. corner, Piroozi Blvd, Mashhad, Iran</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9178843100</zip>
        <telephone>+98 51 3890 9880</telephone>
        <email>chavoshia961@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Amirhossein Chavoshi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 4, No. 5, at the Hekmat sq. corner, Piroozi Blvd, Mashhad, Iran</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9178843100</zip>
        <telephone>+98 51 3890 9880</telephone>
        <email>chavoshia961@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Participants' age should be between 18 to 60 years old.
Patients suffering from dry socket following a tooth extraction who refer to Mashhad dentistry school.
Participants should sign the informed consent.</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Smoking or addiction
Pregnancy and breastfeeding
History of allergy to foods and drugs
Suffering from systemic diseases
Active infective disease (such as hepatitis , AIDS ,TB)
Taking medications which interact with healing process (such as corticosteroids , immunosuppressors ,  anticancer drugs , anticoagulants)
Age under 18 or above 60 years old
History of radiotherapy of head and neck region.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K10.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Alveolar osteitis , Dry socket</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: applying sufficient amount of alveogel manufactured by the Turkish company "Kalsin" in the tooth socket so that it fills the socket and repeating it every 24 hours in case of pain and upon the request of the patient until the complete pain relief.</i_keyword>
      <i_keyword>Intervention group: applying sufficient amount of liquid crystal gel dressing, prepared in Mashhad Faculty of Pharmacy, in the tooth socket so that it fills the socket and repeating it every 24 hours in case of pain and upon the patient's request until the complete pain relief.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Measuring patients' pain upon admission (according to VAS) and examining the intensity of pain after applying each type of dressing. Timepoint: At 30, 60 minutes and 6, 12, 24, 48, 72 hours and 7 days after application and it continues on a daily basis, until the patient has pain. Method of measurement: Questionnaire designed based on Visual Analog Scale (VAS).</prim_outcome>
      <prim_outcome>Checking the number of times the dressing is used. Timepoint: After the complete relief of pain and at the end of the follow-up. Method of measurement: Recording the frequency of dressing use in Excel by the researcher.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Checking the number of Analgesic used for each patient. Timepoint: After the complete relief of pain and at the end of the follow-up. Method of measurement: Asking the patient and recording in Excel by the researcher.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-04-30</approval_date>
        <contact_name>Research ethics committee of Mashhad university of medical sciences</contact_name>
        <contact_address>Research and technology vice-chancellor, Qoreishi building, next to Hoveizeh cinema, Daneshgah street Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
